Frontlight ResearchEarly access
CompletedPhase 4
Two-level ESPB in Total Knee Arthroplasty
Key facts
- Who runs it
- Poznan University of Medical Sciences
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 60 people enrolled
- Started
- 7 Nov 2024
- Ended
- 5 Aug 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- 2 x 20 ml of Ropivacaine 0.2% Injectable Solution
- 2 x 20ml of Ropivacaine 0.2% Injectable Solution
- Record updated
- 25 November 2025
Who can take part
- Age
- 65 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 5 criteriaShow less
Who can take part
- patients scheduled for total hip arthroplasty
- patients aged >65 and <100 years
- patients able to provide informed consent
- patients able to reliably report symptoms to the research team
Who cannot take part
- inability to provide first-party consent due to cognitive impairment or a language barrier
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Effect of two-level ESPB in Total Knee Arthroplasty
The 2 groups in the trial
- iPACK + ACBExisting treatment, for comparison
Ultrasound-guided iPACK +ACB
Treatment: 2 x 20 ml of Ropivacaine 0.2% Injectable Solution
- Two-Level ESPBExisting treatment, for comparison
Bi-level Ultrasound-guided ESPB et the L1 and S1
Treatment: 2 x 20ml of Ropivacaine 0.2% Injectable Solution
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Two-level Erector Spinae vs iPack With ACB Plane Block in Total Knee Arthroplasty
- Record updated
- 25 November 2025